Early activation events differentiate the reactivity of two T-cell families to Staphylococcus enterotoxin A

Cellular Immunology

Volumn 223, Issue 2, 2003, Pages 113-119

  D'Souza, Sushila ^a,b   McGrath, Helen ^a   Sékaly, Rafick P ^a,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^c Pavilion Principal ^*  (Canada)

Author keywords

Bacterial superantigens; Staphylococcal enterotoxin A; T cell activation

Indexed keywords

BACTERIAL TOXIN; CD69 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUTANT PROTEIN; STAPHYLOCOCCUS ENTEROTOXIN A; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS;

EID: 0141727578     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00156-4     Document Type: Article

References (24)

1. Lavoie P.M., Thibodeau J., Erard F., Sékaly R.-P. Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol. Rev. 168:1999;257-269.
2. Fraser J., Arcus V., Kong P., Baker E., Proft T. Superantigens-powerful modifiers of the immune system. Mol. Med. Today. 8:2000;125-132.
3. Li H., Llera A., Malchiodi E.L., Mariuzza R.A. The structural basis of T-cell activation by superantigens. Annu. Rev. Immunol. 17:1999;435-466.
4. Bergdoll M.S., Crass B.A., Reiser R.F., Robbins R.N., Davis J.P. A new staphylococcal enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1:1981;1017-1022.
5. Chesney P.J., Bergdoll M.S., Davis J.P., Vergeron J.M. The disease spectrum epidemiology and etiology of toxic shock syndrome. Annu. Rev. Microbiol. 38:1984;315-338.
6. McKay D.M. Bacterial superantigens: provocateurs of gut dysfunction and inflammation? Trends Immunol. 22:2001;497-501.
7. Paliard X., West S.G., Lafferty J.A., Clements J.R., Kappler J.W., Marrack P., Kotzin B.L. Evidence for the effects of a superantigen in rheumatoid arthritis. Science. 253:1991;325-329.
8. Conrad B., Weissmahr R.N., Boeni J., Arcari R., Schuepbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 90:1997;303-313.
9. Kawabe Y., Ochi A. Selective anergy of Vβ8+ CD4+ T-cells by staphylococcal enterotoxin B-primed mice. J. Exp. Med. 172:1990;1065-1070.
10. Noel C., Florquin S., Goldman M., Braun M.Y. Chronic exposure to superantigen induces regulatory CD4+ T cells with IL-10-mediated suppressive activity. Int. Immunol. 13:2001;431-439.
11. Renno T., Hahne M., MacDonald H.R. Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J. Exp. Med. 181:1995;2283-2287.
12. Thibodeau J., Cloutier I., Lavoie P.M., Labrecque N., Mourad W., Jardetzky T., Sékaly R.-P. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science. 266:1994;1874-1878.
13. Schad E.M., Zaitseva I., Zaitsev V.N., Dohlsten M., Kalland T., Schlievert P.M., Ohlendorf D.H., Svensson L.A. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J. 14:1995;3292-3301.
14. Marrack P., Kappler J. The staphylococcal enterotoxin and their relatives. Science. 248:1990;705-711.
15. Abrahmsén L., Dohlsten M., Segren S., Bjork P., Jonsson E., Kalland T. Characterisation of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J. 14:1995;2978-2986.
16. Valitutti S., Muller S., Celia M., Padovan E., Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature. 375:1995;148-151.
17. Newton D.W., Dohlsten M., Olsson C., Segrén S., Lundin K.E.A., Lando P.A., Kalland T., Kotb M. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T-cell receptor Vβ specificity. J. Immunol. 157:1996;3988-3994.
18. Bachmann M.F., Oxenius A., Speiser D.E., Mariathasan S., Hengartner H., Zinkernagel R.M., Ohashi P.S. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 27:1997;2195-2203.
19. Santis A.G., Lopez-Cabrera M., Sanchez-Madrid F., Proudfoot N. Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs. Eur. J. Immunol. 25:1995;2142-2146.
20. Rosendahl A., Hansson J., Antonsson P., Sékaly R.-P., Kalland T., Dohlsten M. A mutation of F47 to A in Staphylococcus enterotoxin A activates the T-cell receptor Vβ repertoire in vivo. Infect. Immun. 65:1997;5118-5124.
21. Mehindate K., Thibodeau J., Dohlsten M., Kalland T., Sékaly R.-P., Mourad W. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J. Exp. Med. 182:1995;1573-1577.
22. Vella A.T., Kappler J.H., Marrack P. Lipopolysaccharide interferes with the induction of peripheral T-cell death. Immunity. 2:1995;261-270.
23. Lavoie P.M., McGrath H., Shoukry N.H., Cazenave P.-A., Sékaly R.-P., Thibodeau J. Quantitative relationship between MHC Class II-superantigen complexes and the balance of T-cell activation versus death. J. Immunol. 166:2001;7229-7237.
24. Cai Z., Kishimoto H., Brunmark A., Jackson M.R., Peterson P., Sprent J. Requirements for peptide-induced T-cell receptor downregulation on naive CD8+ T-cells? J. Exp. Med. 185:1997;641-645.